These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

663 related items for PubMed ID: 20639738

  • 1. Pregabalin and transcutaneous electrical nerve stimulation for postherpetic neuralgia treatment.
    Barbarisi M, Pace MC, Passavanti MB, Maisto M, Mazzariello L, Pota V, Aurilio C.
    Clin J Pain; 2010 Sep; 26(7):567-72. PubMed ID: 20639738
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of pregabalin for peripheral neuropathic pain: results of an 8-week, flexible-dose, double-blind, placebo-controlled study conducted in China.
    Guan Y, Ding X, Cheng Y, Fan D, Tan L, Wang Y, Zhao Z, Hong Z, Zhou D, Pan X, Chen S, Martin A, Tang H, Cui L.
    Clin Ther; 2011 Feb; 33(2):159-66. PubMed ID: 21444113
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and tolerability of pregabalin using a flexible, optimized dose schedule in Korean patients with peripheral neuropathic pain: a 10-week, randomized, double-blind, placebo-controlled, multicenter study.
    Moon DE, Lee DI, Lee SC, Song SO, Yoon DM, Yoon MH, Kim HK, Lee YW, Kim C, Lee PB.
    Clin Ther; 2010 Dec; 32(14):2370-85. PubMed ID: 21353106
    [Abstract] [Full Text] [Related]

  • 4. A randomized, controlled trial of oxycodone versus placebo in patients with postherpetic neuralgia and painful diabetic neuropathy treated with pregabalin.
    Zin CS, Nissen LM, O'Callaghan JP, Duffull SB, Smith MT, Moore BJ.
    J Pain; 2010 May; 11(5):462-71. PubMed ID: 19962354
    [Abstract] [Full Text] [Related]

  • 5. Replacement of gabapentin with pregabalin in postherpetic neuralgia therapy.
    Ifuku M, Iseki M, Hidaka I, Morita Y, Komatus S, Inada E.
    Pain Med; 2011 Jul; 12(7):1112-6. PubMed ID: 21692969
    [Abstract] [Full Text] [Related]

  • 6. Pregabalin for peripheral neuropathic pain: a multicenter, enriched enrollment randomized withdrawal placebo-controlled trial.
    Gilron I, Wajsbrot D, Therrien F, Lemay J.
    Clin J Pain; 2011 Jul; 27(3):185-93. PubMed ID: 21178603
    [Abstract] [Full Text] [Related]

  • 7. Time to onset of neuropathic pain reduction: A retrospective analysis of data from nine controlled trials of pregabalin for painful diabetic peripheral neuropathy and postherpetic neuralgia.
    Sharma U, Griesing T, Emir B, Young JP.
    Am J Ther; 2010 Jul; 17(6):577-85. PubMed ID: 20393345
    [Abstract] [Full Text] [Related]

  • 8. Pregabalin for postherpetic neuralgia: placebo-controlled trial of fixed and flexible dosing regimens on allodynia and time to onset of pain relief.
    Stacey BR, Barrett JA, Whalen E, Phillips KF, Rowbotham MC.
    J Pain; 2008 Nov; 9(11):1006-17. PubMed ID: 18640074
    [Abstract] [Full Text] [Related]

  • 9. Pregabalin in the treatment of refractory neuropathic pain: results of a 15-month open-label trial.
    Stacey BR, Dworkin RH, Murphy K, Sharma U, Emir B, Griesing T.
    Pain Med; 2008 Nov; 9(8):1202-8. PubMed ID: 18346060
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Gastroretentive gabapentin (G-GR) formulation reduces intensity of pain associated with postherpetic neuralgia (PHN).
    Sang CN, Sathyanarayana R, Sweeney M, DM-1796 Study Investigators.
    Clin J Pain; 2013 Apr; 29(4):281-8. PubMed ID: 22801243
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Long-term efficacy and safety of pregabalin in patients with postherpetic neuralgia: results of a 52-week, open-label, flexible-dose study].
    Ogawa S, Suzuki M, Arakawa A, Yoshiyama T, Suzuki M.
    Masui; 2010 Aug; 59(8):961-70. PubMed ID: 20715519
    [Abstract] [Full Text] [Related]

  • 16. Patient-reported outcomes in subjects with neuropathic pain receiving pregabalin: evidence from medical practice in primary care settings.
    Navarro A, Saldaña MT, Pérez C, Torrades S, Rejas J.
    Pain Med; 2010 May; 11(5):719-31. PubMed ID: 20345618
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Pregabalin versus gabapentin in the treatment of neuropathic pruritus in maintenance haemodialysis patients: a prospective, crossover study.
    Solak Y, Biyik Z, Atalay H, Gaipov A, Guney F, Turk S, Covic A, Goldsmith D, Kanbay M.
    Nephrology (Carlton); 2012 Nov; 17(8):710-7. PubMed ID: 22909343
    [Abstract] [Full Text] [Related]

  • 19. Pregabalin: a novel gamma-aminobutyric acid analogue in the treatment of neuropathic pain, partial-onset seizures, and anxiety disorders.
    Tassone DM, Boyce E, Guyer J, Nuzum D.
    Clin Ther; 2007 Jan; 29(1):26-48. PubMed ID: 17379045
    [Abstract] [Full Text] [Related]

  • 20. Cost-effectiveness of pregabalin for the management of neuropathic pain associated with diabetic peripheral neuropathy and postherpetic neuralgia: a Canadian perspective.
    Tarride JE, Gordon A, Vera-Llonch M, Dukes E, Rousseau C.
    Clin Ther; 2006 Nov; 28(11):1922-34. PubMed ID: 17213013
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.